Scientists at the University of Zurich have developed an innovative neural cell culture model, shedding light on the intricate mechanisms underlying neurodegeneration. Their research pinpointed a misbehaving protein as a ...
Feb 22, 2024
0
26
Using a novel "organ-on-a-chip" model, Baker Heart & Diabetes Institute researchers have discovered a potential therapeutic target that may slow down vascular aging and reduce heart disease, kidney dysfunction and vascular ...
Dec 11, 2023
0
10
A Saint Louis University researcher was instrumental in developing the first and only Food and Drug Administration (FDA) approved treatment for agitation associated with Alzheimer's dementia.
Nov 21, 2023
0
48
Groundbreaking new research has uncovered a potential route to developing the first ever drug treatments for vascular dementia, that directly target a cause of the condition. The research, published in the Proceedings of ...
Aug 7, 2023
0
153
It's difficult to fully predict who will develop Alzheimer's disease in advance. Now, a new study suggests that certain markers in the blood may occur 10 to 20 years before the start of symptoms and could help doctors determine ...
Jul 21, 2023
0
90
Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) are part of an international team that has discovered 61 additional genetic loci associated with stroke and six genes that ...
Oct 5, 2022
0
46
A human stroke drug, fast-tracked by the Food and Drug Administration and soon entering Phase 3 clinical trials, shows intriguing signs that it might also be a safe and powerful defense against Alzheimer's and other forms ...
Dec 1, 2021
0
251
An investigational drug that targets an instigator of the TDP-43 protein, a well-known hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), may reduce the protein's buildup and neurological decline ...
Sep 3, 2020
0
193
The study, carried out by experts from the University of Nottingham and funded by the NIHR School for Primary Care Research, found that there was nearly a 50% increased risk of dementia among patients aged 55 and over who ...
Jun 24, 2019
1
10
In a great stride toward finding an effective treatment for early-stage neurodegenerative diseases, UC Santa Barbara neurobiologist Kenneth S. Kosik and collaborators have uncovered a "druggable" mechanism of pathological ...
Mar 27, 2019
0
50
